TY  - JOUR
T1  - THe ethical hazards and programmatic challenges of genomic newborn screening
AU  - Goldenberg AJ, Sharp RR
Y1  - 2012/02/01
N1  - 10.1001/jama.2012.68
JO  - JAMA
SP  - 461
EP  - 462
VL  - 307
IS  - 5
N2  - 
Advances in next-generation sequencing technologies have the potential to spur better integration of genetic testing into patient care. Appropriate utilization of these technologies will require the capacity to manage, interpret, and communicate large amounts of personal genetic information.1 Because the clinical infrastructure necessary to support these activities is currently limited,2 it is likely that the earliest applications of whole-genome sequencing will be restricted to settings in which genetic testing is already a routine part of clinical or public health practice, such as state newborn screening (NBS) programs.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.68
UR  - http://dx.doi.org/10.1001/jama.2012.68
ER  -